Angelo Cedric F. Panganiban

Angelo Cedric F. Panganiban

Auto-generated profile, based on publicly available information

Angelo Cedric F. Panganiban

University of the Philippines Manila

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024
Verified
Book Chapter
Closed access
PDF file
APAngelo Cedric F. Panganiban
Angelo Cedric F. Panganiban
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
BGBryan Andrei C. Galecio
Bryan Andrei C. Galecio
ISIsabel Teresa Salido
Isabel Teresa Salido
Jaime DL CaroJaime DL Caro
Jaime DL Caro

26 July 2024
Verified
Book Chapter
Closed access
PDF file
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
APAngelo Cedric F. Panganiban
Angelo Cedric F. Panganiban
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
ISIsabel Teresa Salido
Isabel Teresa Salido
RARomuel Aloizeus Z. Apuya
Romuel Aloizeus Z. Apuya
Jaime DL CaroJaime DL Caro
Jaime DL Caro



17 September 2026 in Journal of Alzheimer's Disease Reports
Verified
Journal Article
Open access
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
APAngelo Cedric F. Panganiban
Angelo Cedric F. Panganiban
BGBryan Andrei C. Galecio
Bryan Andrei C. Galecio
MTMichael L. Lucas Tee
Michael L. Lucas Tee
Jaime DL CaroJaime DL Caro
Jaime DL Caro
Background: Virtual reality (VR) is increasingly explored as a novel non-pharmacologic approach to manage Alzheimer's disease, particularly the behavioral and psychological symptoms of dementia. Objective: This phase 1 study aimed to develop an immersive gamification technology system (ImGTS) for the local context and describe its safety, acceptability, and usability among healthy adults prior to clinical deployment in patients with dementia. Methods: The ImGTS was tested on 30 healthy adults using a head-mounted display (HMD; n = 15) or a semi-cave automatic virtual environment (semi-CAVE; n = 15) across four testing sessions. Both qualitative and quantitative questionnaires were administered, with data analyzed through thematic analysis and descriptive statistics. Measures included sense of place, usability, and safety. Results: Participants in both setups reported low VR sickness incidence (four out of 15 participants for both) with decreasing VR sickness questionnaire (VRSQ) scores across sessions (1.50 ± 3.96 to 0 for HMD and 0.78 ± 1.62 to 0 for semi-CAVE). Only mild, mostly oculomotor/disorientation symptoms and slight, transient general discomfort were observed in a minority of participants, using the HMD and semi-CAVE, respectively. Participants also articulated predominantly positive subjective descriptions, with reports of nostalgia and use of strong affective word choices. All participants completed key tasks with little difficulty. The three main activities received “neutral to positive” satisfaction ratings. Conclusions: Overall, our findings indicate that both the HMD and semi-CAVE setups were safe, acceptable, and usable by healthy adult participants. These foundational results support the implementation of phase 2 trials to establish clinical efficacy and tolerability directly within the target population of older individuals living with dementia. Clinical Trial ID: NCT05265182